Journal article
Invasive Pneumococcal Disease Among Immunocompromised Persons: Implications for Vaccination Programs
Abstract
BACKGROUND: In 2012/2013, a single dose of 13-valent pneumococcal conjugate vaccine (PCV13) was recommended for immunocompromised adults in the United States and Canada. To assess the potential benefits of this recommendation, we assessed the serotype-specific burden of invasive pneumococcal disease (IPD) among immunocompromised individuals.
METHODS: From 1995 to 2012, population-based surveillance for IPD was conducted in Metropolitan Toronto …
Authors
Shigayeva A; Rudnick W; Green K; Chen DK; Demczuk W; Gold WL; Johnstone J; Kitai I; Krajden S; Lovinsky R
Journal
Clinical Infectious Diseases, Vol. 62, No. 2, pp. 139–147
Publisher
Oxford University Press (OUP)
Publication Date
January 15, 2016
DOI
10.1093/cid/civ803
ISSN
1058-4838